DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zf57bb/investigation) has announced the addition of the "Investigation Report on China's Atracurium Market, 2010-2019" report to their offering.
According to the Chinese government's statistics, the number of hospitalized cases rose from 115 million in 2008 to 192 million in 2013 with CAGR exceeding 8%, among of which a quarter has to receive operation. As the operation number keeps increasing, the demand for anaesthetic rises too.
Co- developed by Abbott and GlaxoSmithKline, atracurium is a muscle relaxant used in anesthesia whose generic drugs are also produced by such companies as Jiangsu Hengrui Medicine Co., Ltd. According to this market survey, the sales value of atracurium in sample hospitals rose rapidly from less than CNY 20 million in 2005 to over CNY 200 million in 2014 and CAGR during this period reached 45.6%.
Jiangsu Hengrui, Dong Ying (Jiangsu) Pharmaceutical, GlaxoSmithKline (Italy) and Zhejiang Xianju Pharmaceutical Co., Ltd occupy the Chinese market, among which Jiangsu Hengrui reports an increasing share while Dong Ying (Jiangsu) Pharmaceutical and GlaxoSmithKline (Italy) report otherwise. And the price of atracurium products made by different companies vary from region to region and the price of imported atracurium is higher than its domestic counterpart.
As operation numbers keeps increasing in China, the demand for muscle relaxants used in anesthesia rises too. Therefore, atracurium enjoys a vast market in China.
Key Topics Covered:
1 Related Concepts of Atracurium
2 Market Profile of Atracurium in China
3 Survey on Atracurium Sales in China, 2010-2014
4 Survey on Market Share of Major Atracurium Manufacturers in China, 2010-2014
5 Survey on Dosage Forms of Atracurium in China, 2010-2014
6 Reference Price of Atracurium in Chinese Hospitals in 2014
7 Major Manufacturers of Atracurium in Chinese Market, 2010-2014
8 Market Outlook of Atracurium in China, 2015-2019
- Dong Ying (Jiangsu) Pharmaceutical Co., Ltd
- Jiangsu Hengrui Medicine Co., Ltd
- Shanghai Hengrui Pharmaceutical Co., Ltd
- Wellcome Trust
- Zhejiang Xianju Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/zf57bb/investigation